In this video blog, Ron Shapiro, MD, University of Pittsburgh, discusses conversion from cyclosporine to everolimus in stable heart transplant patients.
This review provides a summary of the applications and potential applications of metabolite profiling (i.e. metabolomics) in monitoring organ transplants.
Find out about the connection between surrogate measures of traffic-related air pollution at recipients' home addresses and the development of chronic lung allograft dysfunction.
What are the important differences between outcomes for patients with acute hepatic failure receiving living-donor vs deceased-donor liver transplants?
Can a patient with asymptomatic, persistent bacteriuria be transplanted under antibiotic coverage or should we wait until her urine becomes culture-free?
When is it safe for the patient with chronic renal failure and chronic hepatitis B virus (HBV) infection being treated with lamivudine to be cleared for kidney transplantation?
In the US where wait-list priority depends on maintaining Milan criteria, nonsurgical HCC treatment will likely continue in an effort to forestall tumor progression and waiting list drop-out.
Should preventive treatment for tuberculosis begin while the patient is waiting for transplantation or just immediately with transplantation, when immunosuppression begins?
Induction alemtuzumab prior to cardiac transplant may improve survival and reduce acute rejection while allowing lower-intensity maintenance immunosuppression.